Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

| More on:
A woman jumps for joy with a rocket drawn on the wall behind her.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

AVITA Medical Inc (ASX: AVH) shares are having a strong start to the day.

In morning trade, the ASX healthcare stock is up over 7% to $4.10.

Why is this ASX healthcare stock jumping?

Investors have been buying the regenerative medicine company's shares after it made a big announcement.

According to the release, the United States Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for RECELL GO mini.

The company notes that as a line extension of the existing RECELL GO system, the RECELL GO mini disposable cartridge is designed specifically to treat smaller wounds up to 480 square centimetres. This compares to the standard RECELL GO disposable cartridge, which treats an area of 1,920 square centimetres.

Why the mini version?

Management points out that RECELL GO mini addresses a critical need in the full-thickness skin defect market, which includes a high volume of smaller wounds.

As part of the RECELL GO platform, RECELL GO mini uses the same multi-use processing device as the standard disposable cartridge. However, it features a modified cartridge that is optimised for smaller skin samples. This reduces resource use and minimises waste.

The company feels that this design provides an entry point for clinicians who may not have previously used the RECELL GO platform for smaller wounds, enabling broader accessibility and use in trauma and burn centres.

The ASX healthcare stock's CEO, Jim Corbett, was pleased with the news. He said:

The FDA approval of RECELL GO mini strengthens our ability to provide clinicians with fit-for-purpose solutions that meet the diverse needs of patients with full-thickness wounds. By introducing a treatment option specifically for smaller wounds, we are expanding the accessibility of RECELL to a wider range of patients. We believe this addition will drive greater adoption across trauma centers, where smaller wounds are common, and support our broader growth strategy.

What's next?

The company notes that it expects RECELL GO mini to serve as a growth driver within the broader RECELL GO platform, further advancing the ASX healthcare stock's strategy to expand its impact on patient care.

Its rollout will begin with trauma and burn centres that currently treat smaller wounds during the first quarter of 2025.

Following today's gain, this ASX healthcare stock is now trading largely flat year to date. Though, it remains down by a sizeable 65% over the past five years.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »